Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Following acute myocardial infarction, eosinophil counts 5 to 7 days after onset are associated with risk of long-term mortality Eosinophil counts 5 to 7 days after onset in patients with acute ...

METREX involved patients with a range of eosinophil levels and showed a ... label extended to include chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...